LBRXLB Pharmaceuticals Inc Common Stock

CSNasdaq (XNAS)·USD

Identity

Security key: 17932
Ticker: LBRX
Type: CS — Common Stock
Exchange: Nasdaq(XNAS)
Venue group: NASDAQ
Operating MIC: XNAS
Market: stocks
Locale: us
Currency: USD
Listed: 2025-09-11
Round lot: 100
Active: Yes
Last seen in a load: 2026-08-14 20:49
Vendor updated: 2026-08-13 06:09
Ticker root / suffix: LBRX

Detail

Enriched 2026-08-14 20:47

Market cap: $1,463,921,361.5
Shares outstanding (class): 28,676,652
Shares outstanding (weighted): 32,259,175
SIC: 2834 PHARMACEUTICAL PREPARATIONS
Employees: 27
Location: NEW YORK, NY
Homepage: https://www.lbpharma.us
Description: LB Pharmaceuticals Inc is a late-stage biopharmaceutical company developing novel therapies for the treatment of a wide range of neuropsychiatric disorders including schizophrenia, bipolar depression, adjunctive treatment of depressive disorder and other diseases. It is building a pipeline that leverages the broad therapeutic potential of its product candidate, LB-102, which it believes has the potential to be the first benzamide antipsychotic drug approved for neuropsychiatric disorders in the United States. LB-102 is currently in late-stage clinical development for schizophrenia and bipolar depression. The company operates as a single reportable segment in the development of novel therapies for the treatment of neuropsychiatric diseases, including schizophrenia.

Market cap and share counts drift.

Funds holding this security

60 funds · 62 positions · $78.75M reported value, as of 2026-03-31

All holders →

Fund	Ticker	Position value	% of fund	Balance	Match
JPMorgan Small Cap Growth Fund JPMorgan Trust II	—	$17.98M	0.83%	729,316 NS	FIGI
VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS	VTI	$14.77M	0.00%	599,100 NS	FIGI
iShares Russell 2000 ETF iShares Trust	IWM	$11.69M	0.02%	473,930 NS	FIGI
VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS	VXF	$6.76M	0.01%	274,123 NS	FIGI
JPMorgan Small Cap Blend Fund JPMorgan Trust I	—	$5.81M	0.41%	235,450 NS	FIGI
BlackRock Health Sciences Term Trust —	—	$5.13M	0.51%	207,987 NS	FIGI
State Street(R) SPDR(R) S&P(R) Pharmaceuticals … SPDR SERIES TRUST	XPH	$2.20M	0.71%	89,202 NS	FIGI
iShares Russell 2000 Growth ETF iShares Trust	IWO	$2.03M	0.02%	82,146 NS	FIGI
iShares Russell 2000 Value ETF iShares Trust	IWN	$1.89M	0.02%	76,783 NS	FIGI
iShares U.S. Pharmaceuticals ETF iShares Trust	IHE	$1.68M	0.17%	67,960 NS	FIGI
iShares Micro-Cap ETF iShares Trust	IWC	$1.20M	0.10%	48,515 NS	FIGI
BlackRock Health Sciences Trust —	—	$1.19M	0.22%	48,308 NS	FIGI
iShares Core S&P Total U.S. Stock Market ETF iShares Trust	ITOT	$867.3K	0.00%	35,170 NS	FIGI
Health Sciences Portfolio PACIFIC SELECT FUND	—	$824.8K	0.23%	33,445 NS	FIGI
Master Small Cap Index Series Quantitative Master Series LLC	—	$803.4K	0.02%	32,581 NS	FIGI

How positions resolve to the securities master. FIGI_COMPOSITE is exact identifier equality — both sides got the FIGI from Bloomberg. TICKER is a narrow fallback used only where the master row carries no FIGI at all (2,389 rows do not, disproportionately Irish-domiciled US listings like LIN and ACN). Roughly 22% of all positions resolve to the master.

Funds holding this security

Identifiers

master.security_identifier

TICKERLBRX
FIGI_COMPOSITEBBG00XNP5MQ4
FIGI_SHARE_CLASSBBG00XNP5MR3
CIK0001691082
ISINUS50180M1080
Resolved through OpenFIGI from a holdings ISIN, not supplied by the securities vendor.

Identifiers

Classification

classification.v_security_classification

Asset class: Equity
Sector: Health Care
Industry: Pharmaceuticals
Source: LLMunreviewed
Self-reported confidence: 0.95
Model: deepseek
Rationale: Common stock of a pharmaceutical company, classified under healthcare and pharmaceuticals.

Classifications are unreviewed model output. All 5,771 assignments carry source = LLM and is_reviewed = false. Confidence is the model’s own estimate and is not calibrated — it clustered at 0.90–0.98 across the whole first pass, including rows that later proved wrong. Use it to order a review queue, not as a probability. Two share classes of one issuer can disagree.

Classification

Fund data

Not linked to a fund series.

Either this is not a fund, or it is one the SEC share-class snapshot cannot reach — commodity trusts and notes have no series ID at all.